4//SEC Filing
Garner Todd W 4
Accession 0001127602-23-010058
CIK 0000816956other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:03 PM ET
Size
15.9 KB
Accession
0001127602-23-010058
Insider Transaction Report
Form 4
CONMED CorpCNMD
Garner Todd W
Executive Vice President & CFO
Transactions
- Sale
Common Stock
2023-03-13$88.78/sh−1,300$115,416→ 29,815 total - Exercise/Conversion
Common Stock
2023-03-13$50.61/sh+30,000$1,518,300→ 31,115 total - Sale
Common Stock
2023-03-13$90.30/sh−6,849$618,495→ 22,966 total - Sale
Common Stock
2023-03-13$91.10/sh−17,926$1,633,075→ 5,040 total - Sale
Common Stock
2023-03-13$91.95/sh−3,825$351,690→ 1,215 total - Sale
Common Stock
2023-03-13$92.63/sh−100$9,263→ 1,115 total - Exercise/Conversion
Options To Purchase Common Stock
2023-03-13−30,000→ 5,100 totalExercise: $50.61Exp: 2028-01-02→ Common Stock (30,000 underlying)
Footnotes (6)
- [F1]These trades were made pursuant to a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $88.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.61 to $90.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.615 to $91.61. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.625 to $92.45. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F6]Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.
Documents
Issuer
CONMED Corp
CIK 0000816956
Entity typeother
Related Parties
1- filerCIK 0001726884
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:03 PM ET
- Size
- 15.9 KB